KnowledgeBase

• Home
• Antimicrobials
• Microorganisms
• About Us
• Contact Us

• Search All
• Search by Antimicrobial
• Search by Microorganism
• 

Home › Search by Microorganism › Stenotrophomonas maltophilia (TOT19)

• Stenotrophomonas maltophilia
• Stenotrophomonas maltophilia (1AC736 + L1 + L2)
• Stenotrophomonas maltophilia (1AC739)
• Stenotrophomonas maltophilia (AS 6A)
• Stenotrophomonas maltophilia (ATCC 1363)
• Stenotrophomonas maltophilia (ATCC 13637)
• Stenotrophomonas maltophilia (B715 + L1 + L2)
• Stenotrophomonas maltophilia (CAN-ICU 62584)
• Stenotrophomonas maltophilia (GN 12873)
• Stenotrophomonas maltophilia (GN12873 + carbapenem-resistant)
• Stenotrophomonas maltophilia (I-10717)
• Stenotrophomonas maltophilia (levofloxacin-intermediate)
• Stenotrophomonas maltophilia (levofloxacin-susceptible)
• Stenotrophomonas maltophilia (O-16451)
• Stenotrophomonas maltophilia (polymyxin B-resistant)
• Stenotrophomonas maltophilia (RC1)
• Stenotrophomonas maltophilia (TOT16)
• Stenotrophomonas maltophilia (TOT19)
• Stenotrophomonas maltophilia (TOT43)
• Stenotrophomonas maltophilia (TOT57)
• Stenotrophomonas maltophilia (TOT8)

This project is supported by TOKU-E which specializes in manufacturing ultra-pure antibiotics for a broad spectrum of biotechnology applications as well as for the pharmaceutical industry. TOKU-E is a global leader in biotechnology innovation, offering great benefits and applications to the biopharmaceutical and diagnostic industries as well as for biotechnology research communities.
Privacy Policy | Terms of Use
Knowledgebase version 1.8